BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9160659)

  • 1. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
    Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
    Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin.
    Kimura S; Roberts AW; Metcalf D; Alexander WS
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1195-200. PubMed ID: 9448308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.
    Luoh SM; Stefanich E; Solar G; Steinmetz H; Lipari T; Pestina TI; Jackson CW; de Sauvage FJ
    Mol Cell Biol; 2000 Jan; 20(2):507-15. PubMed ID: 10611229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells.
    Kokorina NA; Granier CJ; Zakharkin SO; Davis S; Rabson AB; Sabaawy HE
    Exp Hematol; 2012 Dec; 40(12):1028-1042.e3. PubMed ID: 22922207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitors.
    Cui L; Moraga I; Lerbs T; Van Neste C; Wilmes S; Tsutsumi N; Trotman-Grant AC; Gakovic M; Andrews S; Gotlib J; Darmanis S; Enge M; Quake S; Hitchcock IS; Piehler J; Garcia KC; Wernig G
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33384332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways.
    Garcia J; de Gunzburg J; Eychène A; Gisselbrecht S; Porteu F
    Mol Cell Biol; 2001 Apr; 21(8):2659-70. PubMed ID: 11283246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the differential impact of thrombopoietin/MPL signaling on hematopoietic stem/progenitor cell function in bone marrow and spleen.
    Lee S; Zhan H
    Stem Cell Reports; 2024 Feb; 19(2):211-223. PubMed ID: 38215758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
    Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
    J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin treats erythropoietin resistance by correcting EPO-induced progenitorcell depletion.
    Zou H; Wong RSM; Yan X
    Biochem Pharmacol; 2024 Feb; 220():116008. PubMed ID: 38154543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12.
    Hall MA; Curtis DJ; Metcalf D; Elefanty AG; Sourris K; Robb L; Gothert JR; Jane SM; Begley CG
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):992-7. PubMed ID: 12552125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of myeloid progenitor cell proliferation/survival by IL-31 receptor and IL-31.
    Broxmeyer HE; Li J; Hangoc G; Cooper S; Tao W; Mantel C; Graham-Evans B; Ghilardi N; de Sauvage FJ
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):78-86. PubMed ID: 17379091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult human megakaryocyte-erythroid progenitors are in the CD34+CD38mid fraction.
    Sanada C; Xavier-Ferrucio J; Lu YC; Min E; Zhang PX; Zou S; Kang E; Zhang M; Zerafati G; Gallagher PG; Krause DS
    Blood; 2016 Aug; 128(7):923-33. PubMed ID: 27268089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of mouse clonogenic megakaryocyte progenitors.
    Nakorn TN; Miyamoto T; Weissman IL
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):205-10. PubMed ID: 12490656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of acute myeloid leukaemia-associated mouse chromosome 2 deletions in X-ray exposed immature haematopoietic progenitors and stem cells.
    Olme CH; Brown N; Finnon R; Bouffler SD; Badie C
    Mutat Res; 2013 Aug; 756(1-2):119-26. PubMed ID: 23665297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin.
    Ono-Uruga Y; Tozawa K; Horiuchi T; Murata M; Okamoto S; Ikeda Y; Suda T; Matsubara Y
    J Thromb Haemost; 2016 Jun; 14(6):1285-97. PubMed ID: 26990635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous expression of Bcl-xL protein during megakaryopoiesis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL.
    Kozuma Y; Kojima H; Yuki S; Suzuki H; Nagasawa T
    J Thromb Haemost; 2007 Jun; 5(6):1274-82. PubMed ID: 17389006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Thrombopoietin/Mpl Signaling in Adult Hematopoiesis Identifies New Candidates for Hematopoietic Stem Cell Maintenance.
    Kohlscheen S; Wintterle S; Schwarzer A; Kamp C; Brugman MH; Breuer DC; Büsche G; Baum C; Modlich U
    PLoS One; 2015; 10(7):e0131866. PubMed ID: 26147434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an in vitro bioassay system for human thrombopoietin by constructing a recombinant murine cell line expressing human thrombopoietin receptor.
    Park H; Hong HJ
    Mol Cells; 1997 Dec; 7(6):699-704. PubMed ID: 9509407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defects in hemopoietic stem cell activity in Ikaros mutant mice.
    Nichogiannopoulou A; Trevisan M; Neben S; Friedrich C; Georgopoulos K
    J Exp Med; 1999 Nov; 190(9):1201-14. PubMed ID: 10544193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a novel mesenchymal stem cell-based regimen for chronic myeloid leukemia differentiation therapy.
    Zuo S; Sun L; Wang Y; Chen B; Wang J; Ge X; Lu Y; Yang N; Shen P
    Cell Death Dis; 2021 Feb; 12(2):208. PubMed ID: 33627636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.